Literature DB >> 29942404

Incidental Detection of Parathyroid Adenoma on Somatostatin Receptor PET/CT and Incremental Role of 18F-Fluorocholine PET/CT in MEN1 Syndrome.

Saurabh Arora1, Nishikant Avinash Damle1, Averilicia Passah1, Madhav Prasad Yadav1, Sanjana Ballal1, Vivek Aggarwal2, Yashdeep Gupta3, Praveen Kumar1, Madhavi Tripathi1, Chandrasekhar Bal1.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) syndrome is characterized by combined occurrence of tumors of endocrine glands including the parathyroid, the pancreatic islet cells, and the anterior pituitary gland. Parathyroid involvement is the most common manifestation and usually the first clinical involvement in MEN1 syndrome, followed by gastroentero-pancreatic neuroendocrine tumors (NETs). Here we present a case where the patient initially presented with metastatic gastric NET and a single parathyroid adenoma was detected incidentally on 68Ga-DOTANOC PET/CT done as part of post 177Lu-DOTATATE therapy (PRRT) follow-up. Further 18F-fluorocholine PET/CT showed four adenomas for which the patient subsequently underwent subtotal parathyroidectomy.

Entities:  

Keywords:  177Lu-DOTATATE therapy; 18F-Fluorocholine PET/CT; Gastrinoma; Hyperparathyroidism; MEN1

Year:  2018        PMID: 29942404      PMCID: PMC5995772          DOI: 10.1007/s13139-018-0520-2

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  18 in total

1.  Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.

Authors:  Sophia Koukouraki; Ludwig G Strauss; Vassilios Georgoulias; Michael Eisenhut; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

Review 2.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 3.  Multiple endocrine neoplasia type 1: clinical and genetic topics.

Authors:  S Marx; A M Spiegel; M C Skarulis; J L Doppman; F S Collins; L A Liotta
Journal:  Ann Intern Med       Date:  1998-09-15       Impact factor: 25.391

4.  Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.

Authors:  Peter Langer; Peter H Kann; Volker Fendrich; Gerd Richter; Saskia Diehl; Matthias Rothmund; Detlef K Bartsch
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

Review 5.  Thyroid and parathyroid imaging.

Authors:  C R Hopkins; C C Reading
Journal:  Semin Ultrasound CT MR       Date:  1995-08       Impact factor: 1.875

6.  Incremental role of 18F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism.

Authors:  Abhishek Behera; Nishikant Avinash Damle
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

Review 7.  Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

8.  Multiple endocrine neoplasia type 1.

Authors:  R V Thakker
Journal:  Indian J Endocrinol Metab       Date:  2012-12

Review 9.  Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?

Authors:  Francesca Giusti; Francesco Tonelli; Maria Luisa Brandi
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 10.  Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.

Authors:  Cornelis J Lips; Koen M Dreijerink; Jo W Höppener
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more
  2 in total

1.  Ectopic Parathyroid Adenoma Mimicking as a Neuroendocrine Tumor on Ga68- DOTANOC Positron Emission Tomography/Computed Tomography Imaging.

Authors:  Karthikeyan Subramanian; Venkata Subramanian Krishnaraju; Rajender Kumar; Sanjay Bhadada; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2021-12-15

Review 2.  Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature.

Authors:  Morten Bentestuen; Farid Gossili; Charlotte Elberling Almasi; Helle Damgaard Zacho
Journal:  Cancer Imaging       Date:  2022-09-03       Impact factor: 5.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.